WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Relay Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas CatinazzoChief Financial Officer2026-01-281,695$8.45
$14.32kSell
Peter RahmerChief Corporate Development Officer2026-01-281,354$8.45
$11.44kSell
Donald A. BergstromPresident RD2026-01-282,686$8.45
$22.70kSell
Thomas CatinazzoChief Financial Officer2026-01-2713,820$7.62
$105.31kSell
Donald A. BergstromPresident RD2026-01-2718,895$7.62
$143.98kSell
Peter RahmerChief Corporate Development Officer2026-01-2711,684$7.62
$89.03kSell
Sanjiv PatelPresident and CEO2026-01-0643,168$7.82
$337.57kSell
Peter RahmerChief Corporate Development Officer2025-12-31994$2.99
$2.97kBuy
Sanjiv PatelPresident and CEO2025-12-31994$2.99
$2.97kBuy
Sanjiv PatelPresident and CEO2025-11-0362,073$7.00
$434.51kSell

1 of 5

RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLAY insiders and whales buy or sell their stock.

RLAY Shareholders

What type of owners hold Relay Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Svf Pauling Cayman Ltd16.10%27,904,963$249.19MInsider
Blackrock Inc7.63%13,228,502$118.13MInstitution
Third Rock Ventures III LP6.09%10,551,115$94.22MInsider
Vanguard Group Inc5.59%9,691,445$86.54MInstitution
State Street Corp3.71%6,426,111$57.39MInstitution
Geode Capital Management LLC1.97%3,409,363$30.45MInstitution
Picularium LLC1.89%3,281,253$29.30MInsider
Spruce Street Capital LP1.72%2,984,125$26.65MInstitution
Dimensional Fund Advisors LP1.43%2,480,350$22.15MInstitution
Sanjiv Patel1.28%2,222,492$19.85MInsider

1 of 3

RLAY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLAY33.40%27.49%Net SellingNet Selling
ORKA10.82%89.18%Net BuyingNet Selling
RAPT21.96%78.04%
OCS27.05%0.00%
NRIX57.76%8.27%Net SellingNet Buying
View Top Biotech Stocks

Relay Therapeutics Stock Ownership FAQ

Who owns Relay Therapeutics?

Relay Therapeutics (NASDAQ: RLAY) is owned by 33.40% institutional shareholders, 27.49% Relay Therapeutics insiders, and 39.10% retail investors. Svf Pauling Cayman Ltd is the largest individual Relay Therapeutics shareholder, owning 27.90M shares representing 16.10% of the company. Svf Pauling Cayman Ltd's Relay Therapeutics shares are currently valued at $255.61M.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.